Clinicopathological analysis of sinonasal malignant lymphoma in an HTLV-1 endemic area in Japan -special focus on primary sinonasal diffuse large B-cell lymphoma

Journal of Clinical and Experimental Hematopathology : JCEH
Daisuke MurakamiTakashi Nakagawa

Abstract

The present study investigated histological subtypes of lymphoma in patients newly diagnosed with malignant lymphoma in the human T-cell leukemia virus type 1 (HTLV-1) endemic area of Japan, and further analyzed the clinicopathological features and clinical outcomes of patients with primary sinonasal lymphoma. We retrospectively examined 151 patients aged 18-90 years in Fukuoka, Japan. Subtypes of lymphoma were determined according to the WHO classification. Among the 151 patients, 104 were diagnosed with malignant lymphoma, including 96 at the time of initial diagnosis. Ninety-two of the 96 lymphomas (96%) were non-Hodgkin lymphoma. Mature B-cell neoplasms comprised 78% (n = 75). Primary lymphoma of the sinonasal cavity was found in six patients (6%). The histological subtype of sinonasal lymphoma was diffuse large B-cell lymphoma (DLBCL) in all six tumors. Furthermore, overall survival was significantly different among three distinct DLBCL patient groups, including primary sinonasal lymphoma patients (p = 0.0016; 3-year overall survival: sinonasal DLBCL group, 53%; DLBCL of the CNS group, 0%; other DLBCL group, 83%). Our study suggests that primary DLBCL of the sinonasal tract is a distinct disease entity of DLBCL.

References

Jan 1, 1989·Virchows Archiv. A, Pathological Anatomy and Histopathology·C FellbaumK Lennert
Sep 13, 2000·The Laryngoscope·M S QuraishiP J Bradley
Aug 9, 2005·Hematology/oncology Clinics of North America·James L RubensteinJoan M O'Brien
Feb 7, 2008·Pathology International·Ryosuke AokiKoichi Ohshima
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jack PhanBouthaina Shbib Dabaja
Jun 19, 2013·Best Practice & Research. Clinical Haematology·Basem M William, James O Armitage
Nov 12, 2013·American Journal of Otolaryngology·Vivek V KanumuriJean Anderson Eloy
Nov 20, 2013·British Journal of Haematology·Dai ChiharaKeitaro Matsuo

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
flow cytometry

Software Mentioned

JMP
GraphPad
GraphPad Prism

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.